Key Points of Immunohistochemistry Laboratory Quality Control and Development Trends in Automation

Core Elements of the Quality Control System in Immunohistochemistry Laboratories

Immunohistochemistry (IHC) involves numerous experimental steps and complex influencing factors, and establishing a comprehensive quality control system is a prerequisite for ensuring reliable results. Quality control should cover three phases: pre-analytical, analytical, and post-analytical. The pre-analytical phase includes sample fixation, tissue sampling, embedding, and section quality assessment; the analytical phase focuses on reagent validity, incubation conditions, instrument status, and control setup; the post-analytical phase involves result interpretation, report review, and archiving for traceability.

Laboratories should establish standard operating procedures that define the acceptable fluctuation ranges for key steps. For example, the pH value of antigen retrieval solution, retrieval time and temperature, antibody incubation time and temperature, and DAB development time should all be documented. When reagent lots are replaced periodically, a comparison between old and new lots is required to prevent lot-to-lot variation from affecting result stability.

Common Causes of Out-of-Control Results and Corrective Measures

When immunohistochemical staining shows all-negative results, all-positive results, excessive background, or abnormal localization, there are usually traceable causes. All-negative results may be related to primary antibody failure, insufficient antigen retrieval, or a non-functioning detection system; all-positive results may be related to inadequate blocking of endogenous enzymes or nonspecific binding of secondary antibodies. Excessive background may also result from sections that are too thick, incomplete washing, or insufficient blocking time.

Corrective measures should proceed from simple to complex in a stepwise manner. First check the control sections and reagent expiration dates, then review the day's operation records, and repeat staining if necessary. Each out-of-control analysis should document the cause and corrective outcome as a basis for continuous improvement. External quality assessment and internal blinded sample testing can also help identify problems.

Automation and Digitalization Facilitate the Development of Immunohistochemistry

Automated immunohistochemistry staining platforms have increasingly entered pathology laboratories, with advantages including reduced manual operation variability, improved pipetting accuracy, and standardized incubation and washing. Common automated platforms generally support simultaneous processing of multiple slides and can be preprogrammed to control staining conditions for different antibodies. When introducing automated equipment, laboratories should perform installation qualification, operational qualification, and performance qualification, and compare it with the original method.

Digital pathology and image analysis technologies provide new tools for interpreting immunohistochemistry results. By performing whole-slide scanning of stained slides and combining algorithmic analysis of positive cell proportion and staining intensity, consistency in interpretation can be assisted for pathologists. However, digital analysis still requires manual review to ensure accurate morphological assessment. With the development of artificial intelligence and laboratory information systems, full-process traceability and intelligent management of immunohistochemistry testing will gradually become widespread, providing a more solid foundation for precision diagnosis.